Podcast: De-Risking Drug Development
In the final episode of the ParexelBiotech podcast series, “De-Risking Drug Development,” host Paul Bridges welcomes TMAC CEO David Hahn and an expert panel as they focus on post-launch market development and how to expand the use and value of your product over time. Exploring lifecycle optimization for biotech companies, experts Miriam Carr, Earl Sands, and David Hahn discuss the importance of planning as early as Phase 1-2 clinical trials and thinking globally from the outset. They discuss an agile outsourcing model, the value of proper resourcing, an alternative definition for target product potential (TPP), and the future possibilities and opportunities for products beyond initial approval.
Pre-Launch MSLs Invaluable to Treatment Adoption
The recently released Veeva Pulse Field Trend’s Report revealed clear findings that the utilization of field-medical liaisons pre-launch significantly impacts clinical practices’ adoption of a treatment by a 1.5- fold increase in the first 6-months post-launch compared to products not being supported with MSLs. Translating science into a commercially agreeable language early on is, without a doubt, critical.
Virtual MSL Engagements
“Because of the COVID-19 pandemic, we can no longer count on in-person engagements to properly serve our customers. Credibility comes in bringing value to the KOL. Establishing credibility really works the same in any environment.”
TMAC’s Virtual MSL Hub
TMAC has been virtually engaging with customers for over two decades. Our teams deliver on-demand, proactive and reactive communications to meet your needs.
Outsourcing an MSL Team Provides Exceptional Benefits
Outsourcing can provide greater budget flexibility and control by allowing organizations to pay for the services and business functions they need, when they need them.
Maximize Your KOL Time
New reality: virtual engagements are changing the MSL to KOL relationship. From shorter meetings and decreased numbers of engagements, to a reliance on new technology platforms. How do you harness these changes to your advantage and continue to make an impact?
